{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:19:51Z","timestamp":1775211591840,"version":"3.50.1"},"reference-count":13,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>A transcription factor called SALL4 could be the missing link between thalidomide and the limb defects caused by the drug.<\/jats:p>","DOI":"10.7554\/elife.41002","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T15:00:13Z","timestamp":1537887613000},"source":"Crossref","is-referenced-by-count":6,"title":["Unlocking a dark past"],"prefix":"10.7554","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-5011","authenticated-orcid":true,"given":"Fernando","family":"Rodr\u00edguez-P\u00e9rez","sequence":"first","affiliation":[{"name":"Howard Hughes Medical Institute, University of California, Berkeley, United States"},{"name":"Department of Molecular and Cell Biology, University of California, Berkeley, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-6343","authenticated-orcid":true,"given":"Michael","family":"Rape","sequence":"additional","affiliation":[{"name":"Howard Hughes Medical Institute, University of California, Berkeley, United States"},{"name":"Department of Molecular and Cell Biology, University of California, Berkeley, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4374","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1136\/jmg.2004.019505","article-title":"Novel mutations in the gene SALL4 provide further evidence for acro-renal-ocular and Okihiro syndromes being allelic entities, and extend the phenotypic spectrum","volume":"41","author":"Borozdin","year":"2004","journal-title":"Journal of Medical Genetics"},{"key":"bib2","volume-title":"Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine","author":"Brynner","year":"2001"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/acs.jmedchem.7b01272","article-title":"Protac-induced protein degradation in drug discovery: breaking the rules or just making new ones?","volume":"61","author":"Churcher","year":"2018","journal-title":"Journal of Medicinal Chemistry"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"e38430","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray Syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"eLife"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1093\/hmg\/11.23.2979","article-title":"Okihiro syndrome is caused by SALL4 mutations","volume":"11","author":"Kohlhase","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/jmg.40.7.473","article-title":"Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy","volume":"40","author":"Kohlhase","year":"2003","journal-title":"Journal of Medical Genetics"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng1707","article-title":"Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart","volume":"38","author":"Koshiba-Takeuchi","year":"2006","journal-title":"Nature Genetics"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/tera.1420380303","article-title":"A short history of thalidomide embryopathy","volume":"38","author":"Lenz","year":"1988","journal-title":"Teratology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"PNAS"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/41002\/elife-41002-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/41002\/elife-41002-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/41002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:01:57Z","timestamp":1697072517000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/41002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":13,"alternative-id":["10.7554\/eLife.41002"],"URL":"https:\/\/doi.org\/10.7554\/elife.41002","archive":["CLOCKSS"],"relation":{},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"article-number":"e41002"}}